An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022249
Company: CEPHALON

Summary Review

Products on NDA 022249

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TREANDA	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	Yes	Yes
TREANDA	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	Yes	Yes
TREANDA	BENDAMUSTINE HYDROCHLORIDE	45MG/0.5ML (90MG/ML)	SOLUTION;INTRAVENOUS	Discontinued	None	Yes	No
TREANDA	BENDAMUSTINE HYDROCHLORIDE	180MG/2ML (90MG/ML)	SOLUTION;INTRAVENOUS	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022249

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/20/2008	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022249lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022249s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/treanda_022249_TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/22249s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/25/2022	SUPPL-26	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022249s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/022249Orig1s026ltr.pdf
06/10/2021	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022249s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022249Orig1s025ltr.pdf
11/21/2019	SUPPL-24	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022249s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022249Orig1s024ltr.pdf
12/15/2017	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022249s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022249Orig1s023ltr.pdf
10/18/2016	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022249s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022249Orig1s022ltr.pdf
09/02/2015	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022249Orig1s021ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/022249Orig1s021.pdf
11/05/2015	SUPPL-20	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022249Orig1s020ltr.pdf
03/10/2015	SUPPL-19	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249Orig1s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022249Orig1s019ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/022249Orig1s019.pdf
07/08/2015	SUPPL-18	Manufacturing (CMC)		Label is not available on this site.
03/27/2014	SUPPL-17	Manufacturing (CMC)		Label is not available on this site.
09/13/2013	SUPPL-15	Manufacturing (CMC)	Label (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022249s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/022249Orig1s015.pdf
08/28/2013	SUPPL-14	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022249s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022249Orig1s014ltr.pdf
06/26/2012	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022249s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022249s012ltr.pdf
12/21/2010	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022249s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022249s006ltr.pdf
02/26/2010	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022249s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022249s005ltr.pdf
04/22/2009	SUPPL-2	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022249s002,022303s000ltr.pdf
05/01/2009	SUPPL-1	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF) Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022249s001ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022249Orig1s001.pdf

Labels for NDA 022249

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/25/2022	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022249s026lbl.pdf
06/10/2021	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022249s025lbl.pdf
11/21/2019	SUPPL-24	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022249s024lbl.pdf
12/15/2017	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022249s023lbl.pdf
10/18/2016	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022249s022lbl.pdf
11/05/2015	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249s020lbl.pdf
09/02/2015	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249s021lbl.pdf
03/10/2015	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249Orig1s019lbl.pdf
03/10/2015	SUPPL-19	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249Orig1s019lbl.pdf
09/13/2013	SUPPL-15	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022249s015lbl.pdf
08/28/2013	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022249s014lbl.pdf
06/26/2012	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022249s012lbl.pdf
12/21/2010	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022249s006lbl.pdf
02/26/2010	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022249s005lbl.pdf
05/01/2009	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s001lbl.pdf
05/01/2009	SUPPL-1	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s001lbl.pdf
04/22/2009	SUPPL-2	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s002lbl.pdf
03/20/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022249lbl.pdf

Therapeutic Equivalents for NDA 022249

TREANDA

POWDER;INTRAVENOUS; 100MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	205574	ACCORD HLTHCARE
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	204230	APOTEX
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	205376	DR REDDYS
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	214739	EUGIA PHARMA
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211001	MEITHEAL
TREANDA	BENDAMUSTINE HYDROCHLORIDE	100MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	022249	CEPHALON

POWDER;INTRAVENOUS; 25MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	205574	ACCORD HLTHCARE
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	204230	APOTEX
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	205376	DR REDDYS
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	214739	EUGIA PHARMA
BENDAMUSTINE HYDROCHLORIDE	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211001	MEITHEAL
TREANDA	BENDAMUSTINE HYDROCHLORIDE	25MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	022249	CEPHALON

Top